RPA3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.919800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.770600E-01
Normal-vs-Stage2
2.864000E-01
Normal-vs-Stage3
9.621200E-01
Normal-vs-Stage4
3.069200E-01
Stage1-vs-Stage2
4.243200E-01
Stage1-vs-Stage3
4.625000E-01
Stage1-vs-Stage4
3.745600E-01
Stage2-vs-Stage3
1.996820E-01
Stage2-vs-Stage4
8.716000E-01
Stage3-vs-Stage4
2.761800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.166000E-01
Normal-vs-AfricanAmerican
1.704560E-01
Normal-vs-Asian
2.381600E-01
Caucasian-vs-AfricanAmerican
5.561400E-01
Caucasian-vs-Asian
5.863000E-01
AfricanAmerican-vs-Asian
8.760800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.914400E-01
Normal-vs-Female
3.087200E-01
Male-vs-Female
6.425600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.879200E-01
Normal-vs-Age(41-60Yrs)
2.014200E-01
Normal-vs-Age(61-80Yrs)
3.847400E-01
Normal-vs-Age(81-100Yrs)
2.068800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.983200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.164600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.623800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.652480E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.157800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.308000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.018200E-01
Normal-vs-Daily Drinker
2.876400E-01
Normal-vs-Weekly Drinker
3.667600E-01
Normal-vs-Occasional Drinker
2.472600E-01
Normal-vs-Social Drinker
2.910200E-01
Non Drinker-vs-Daily Drinker
5.529600E-01
Non Drinker-vs-Weekly Drinker
4.157600E-01
Non Drinker-vs-Occasional Drinker
1.656560E-01
Non Drinker-vs-Social Drinker
5.192600E-01
Daily Drinker-vs-Weekly Drinker
7.381800E-01
Daily Drinker-vs-Occasional Drinker
4.089800E-01
Daily Drinker-vs-Social Drinker
9.087600E-01
Weekly Drinker-vs-Occasional Drinker
7.230400E-01
Weekly Drinker-vs-Social Drinker
8.358200E-01
Occasional Drinker-vs-Social Drinker
5.300200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.990600E-01
Normal-vs-Grade 2
7.221800E-01
Normal-vs-Grade 3
7.884400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.655200E-01
Grade 1-vs-Grade 3
2.082100E-02
Grade 1-vs-Grade 4
6.990600E-01
Grade 2-vs-Grade 3
2.563800E-02
Grade 2-vs-Grade 4
7.221800E-01
Grade 3-vs-Grade 4
7.884400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.726400E-01
Normal-vs-NonDiabetic
2.503400E-01
Diabetic-vs-NonDiabetic
1.107380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.481040E-01
Normal-vs-NoPancreatitis
3.029400E-01
Pancreatitis-vs-NoPancreatitis
7.416600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.745560E-01
Normal-vs-N1
3.227000E-01
N0-vs-N1
9.809600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.579900E-02
Normal-vs-TP53-NonMutant
3.988000E-01
TP53-Mutant-vs-TP53-NonMutant
7.51469999999976E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
